Performance Enhancing Drugs Market Grow at a Remarkable Pace in the Coming Years

Posted by vinit sawant on March 19th, 2021

The global performance enhancing drugs market size is predicted to grow at a 4.8% CAGR over the forecast period (2017-2023), as per the latest Market Research Future (MRFR) report.

Performance enhancing drugs, simply put, are different substances, procedures, or chemical agents that are designed to offer advantages during athletic performance

On the contrary, the use of performance enhancing drugs leads to numerous side effects such as heart attack and masculinization and heart attack in females, and diminished sperm production and acne in males. This may impact the performance enhancing drugs market growth over the forecast period.

Various factors are propelling the performance enhancing drugs market growth. These factors, as stated by the MRFR report, include rising use of anabolic steroids to treat various medical conditions such as anemia, pain management, and certain types of breast cancer, availability of huge funds for research and development activities, and various benefits for athletes such as muscle enlargement and increased blood's oxygen carrying capacity.

Regional Analysis

The performance enhancing drugs market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to rising acceptance of performance-enhancing drugs in the region and accessibility of funds for R&D activities.

The performance enhancing drugs market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to the presence of immense opportunity in the market, continuously developing economies, and rising awareness about performance enhancing drugs.